Vertex Pharmaceuticals (VRTX) Momentum

    Healthcare
    Market data as of 2026-09-04 · Autonium metric computed 2026-09-04 · model v1

    VRTX momentum — the short answer

    VRTX has returned +12.8% over one month, +22.2% over three months and +37.6% over twelve months.

    Returns

    1 week+0.8%
    1 month+12.8%
    3 months+22.2%
    6 months+19.6%
    12 months+37.6%

    Signal drivers

    MomentumNeutral
    Technical trendNeutral
    VolatilityNeutral
    SentimentNeutral

    Sector peers — 3-month return

    LLY — Eli Lilly and Co.1.6
    UNH — UnitedHealth Group-0.6
    JNJ — Johnson & Johnson18.2
    ABBV — AbbVie Inc.12.9
    MRK — Merck & Co.24.5

    Track VRTX inside Autonium

    Full factor detail, alerts when the score changes, and Toni to ask why.

    Type a ticker

    Continue analysing VRTX

    Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.